Guirguis, Micheal
41  results:
Search for persons X
?
 
?
4

A Framework for Evaluating the Implementation of Biosimilar..:

Milgram, Lisa ; Wheeler, Sarah ; Adamic, Andrea...
https://www.cjhp-online.ca/index.php/cjhp/article/view/3272/4876.  , 2023
 
?
 
?
7

DOAC drug interactions management resource:

Chadha, Ayush ; Guirguis, Micheal ; Bungard, Tammy J.
Canadian Pharmacists Journal / Revue des Pharmaciens du Canada.  155 (2022)  6 - p. 315-325 , 2022
 
?
8

DOAC drug interactions management resource:

Chadha, Ayush ; Guirguis, Micheal ; Bungard, Tammy J
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647398/.  , 2022
 
?
9

Prevalence of Venous Thromboembolism and Anticoagulant Use ..:

Schultz, Lynnea ; Bungard, Tammy J ; Mackay, Elizabeth..
https://www.cjhp-online.ca/index.php/cjhp/article/view/3209/4754.  , 2022
 
?
12

Qualitative Examination of Shared Decision-Making in Canada..:

Guirguis, Micheal ; Thompson, Erin ; Miller, Jenna...
Journal of Patient Experience.  8 (2021)  - p. 237437352110641 , 2021
 
?
14

Effect on Patients' Outcomes of a Change to Biosimilar Filg..:

Fenna, Jennifer ; Guirguis, Micheal ; Ibrahim, Caroline...
https://www.cjhp-online.ca/index.php/cjhp/article/view/3108/4394.  , 2021
 
1-15